专利检索 ap:("PROMETHEUS BIOSCIENCES, INC." OR "CEDARS-SINAI MEDICAL CENTER") AND inv:"Olivier LAURENT" 第 1 页

1.

发明公开
ANTI-TL1A ANTIBODY COMPOSITIONS AND METHODS OF TREATMENT IN THE LUNG 审中-公开

公开(公告)号：US20240336691A1

公开(公告)日：2024-10-10

申请号：US18546947

申请日：2022-02-17

申请人： PROMETHEUS BIOSCIENCES, INC. , CEDARS-SINAI MEDICAL CENTER

发明人： Allison LUO , Olivier LAURENT , Ernesto J. MUNOZ , Janine BILSBOROUGH , Bradley HENKLE , Stephan R. TARGAN , Dermot P. MCGOVERN

IPC分类号： C07K16/28 , A61K47/02 , A61K47/12 , A61K47/18 , A61K47/22 , A61K47/26 , A61P11/00

CPC分类号： C07K16/2875 , A61K47/02 , A61K47/12 , A61K47/183 , A61K47/22 , A61K47/26 , A61P11/00 , C07K2317/21

摘要： Described herein are humanized anti-TL1A antibodies and pharmaceutical compositions for the treatment of diseases and/or conditions in the lung.

2.

发明公开
COMPOSITIONS COMPRISING HUMANIZED ANTIBODIES TO TNF-LIKE LIGAND 1A (TL1A) AND USES THEREOF 审中-公开

公开(公告)号：US20240309104A1

公开(公告)日：2024-09-19

申请号：US18546938

申请日：2022-02-17

申请人： PROMETHEUS BIOSCIENCES, INC. , CEDARS-SINAI MEDICAL CENTER

发明人： Allison LUO , Lauren OTSUKI , Mark MANNING , Robert PAYNE , Olivier LAURENT , Janine BILSBOROUGH , Bradley HENKLE , Stephan R. TARGAN

IPC分类号： C07K16/28 , A61K39/00 , A61P1/00 , A61P1/04

CPC分类号： C07K16/2875 , A61P1/00 , A61P1/04 , A61K2039/505 , A61K2039/545

摘要： Described herein are humanized anti-TL1A antibodies and pharmaceutical compositions for the treatment of inflammatory bowel disease (IBD), such as Crohn's Disease (CD) and ulcerative colitis (UC).

3.

发明公开
ANTI-CD30L ANTIBODIES AND USES THEREOF 审中-公开

公开(公告)号：US20240254246A1

公开(公告)日：2024-08-01

申请号：US18546955

申请日：2022-02-16

申请人： PROMETHEUS BIOSCIENCES, INC. , DR. FALK PHARMA GMBH

发明人： Jessie-Farah FECTEAU , Mark RENSHAW , Johan FRANSSON , Olivier LAURENT , Burton BARNETT

IPC分类号： C07K16/28 , A61K39/00 , A61P37/06

CPC分类号： C07K16/2875 , A61P37/06 , A61K2039/505 , C07K2317/24 , C07K2317/52 , C07K2317/565 , C07K2317/732 , C07K2317/734 , C07K2317/76 , C07K2317/92

摘要： Described herein are anti-CD30L antibodies and pharmaceutical compositions for the treatment of autoimmune diseases and disorders such inflammatory bowel disease (IBD), including Crohn's Disease (CD) and ulcerative colitis (UC).

4.

发明申请
ANTI-CD30L ANTIBODIES AND USES THEREOF 有权

公开(公告)号：US20230060624A1

公开(公告)日：2023-03-02

申请号：US17822598

申请日：2022-08-26

申请人： PROMETHEUS BIOSCIENCES, INC. , DR. FALK PHARMA GMBH

发明人： Jessie-Farah FECTEAU , Mark RENSHAW , Johan FRANSSON , Olivier LAURENT , Burton BARNETT

IPC分类号： C07K16/28 , A61P37/06

摘要： Described herein are anti-CD30L antibodies and pharmaceutical compositions for the treatment of autoimmune diseases and disorders such inflammatory bowel disease (IBD), including Crohn's Disease (CD) and ulcerative colitis (UC).

5.

发明公开
ANTI-CD30L ANTIBODIES AND USES THEREOF 审中-公开

公开(公告)号：US20240092923A1

公开(公告)日：2024-03-21

申请号：US18510511

申请日：2023-11-15

申请人： PROMETHEUS BIOSCIENCES, INC. , DR. FALK PHARMA GMBH

发明人： Jessie-Farah FECTEAU , Mark RENSHAW , Johan FRANSSON , Olivier LAURENT , Burton BARNETT

IPC分类号： C07K16/28 , A61P37/06

CPC分类号： C07K16/2878 , A61P37/06 , C07K16/2875 , A61K2039/505

摘要： Described herein are anti-CD30L antibodies and pharmaceutical compositions for the treatment of autoimmune diseases and disorders such inflammatory bowel disease (IBD), including Crohn's Disease (CD) and ulcerative colitis (UC).